echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > High value consumables of Anhui medicine are purchased with quantity, and a large number of dealers are out of the market

    High value consumables of Anhui medicine are purchased with quantity, and a large number of dealers are out of the market

    • Last Update: 2019-07-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [policies and regulations of pharmaceutical Station] on July 16, Anhui Medical Insurance Bureau, health and Health Commission, Department of Finance and Drug Administration jointly issued the notice of implementation plan for negotiation and negotiation (pilot) of high value medical consumables centralized purchase of public medical institutions in Anhui Province (hereinafter referred to as "implementation plan") According to the implementation plan, Anhui Province starts to purchase high-value orthopedic implant (spine) and ophthalmic (intraocular lens) consumables in volume The first task of the implementation plan is to negotiate price reduction, reduce the purchase price of consumables and the transaction cost of enterprises, and purify the circulation environment Industry analysis, two types of high-value consumables first, this policy not only sharp price reduction, but also must "two vote system", it is expected that a large number of dealers will be out The so-called high value consumables refer to that only the bidding price, but no quantity, the winning enterprise also needs to organize the sales team to work in the hospital, so as to promote the use and sale of high value consumables On the other hand, volume purchase promises the sales volume of high-value consumables at the time of bidding, and ensures that they will be used up within one year This is the so-called "purchase with quantity, price for quantity" It is reported that the enterprises participating in the volume purchase include the high-value medical consumables manufacturers approved by the national drug regulatory authority and sold in mainland China, which are listed in the centralized purchase catalogue of Anhui drug procurement platform (the national general agent of imported consumables is regarded as the manufacturer) Although the current pilot is mainly public medical institutions in Anhui Province, Hu Jinglin, director of the State Medical Security Bureau, went to Anhui Province to investigate the high-value consumables belt purchase work from June 26 to 28 this year, after Anhui Province held the high-value consumables belt purchase meeting Hu Jinglin pointed out that in accordance with the reform requirements of the CPC Central Committee on the management of high-value medical consumables, the pilot work should be carried out well, so as to accumulate experience for the national management of high-value medical consumables, and effectively reduce the burden of medical treatment for the masses Industry insiders also pointed out the difficulties of high-value consumables with volume procurement, which mainly lie in "consistency", consistency of classification, consistency of quality, and consistency of use mode, which has actually become the difficulty of high-value consumables with volume procurement However, the implementation plan is really "quantity for price" After the purchase of drugs "4 + 7" with quantity, many brands have not won the bid, which is not very big One important reason is that drugs can make up for a part of the market share decline outside the hospital, but many consumables are not good, such as orthopedic consumables In addition, many high-value consumables cannot be used in hospitals with low level of surgery or insufficient medical care Even if the hospitals in other provinces are changed, it is difficult to expand the market in a short period of time, which requires a relatively long clinical training cycle However, with the implementation of the national "unified coding" of medical consumables by the State Medical Insurance Bureau, the State Food and Drug Administration issued the file review document of medical device product registration project to carry out the consistency evaluation on the technical link of medical device registration The difficulties of high-value consumables purchasing with quantity are all solved one by one, and it is only a matter of time before the whole country pushes forward But we can be sure that the concentration of high-value consumables will be greatly improved In addition, the circulation sector is also expected to be greatly affected.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.